Inventor · disambiguated record
Branislav Musicki
Also filed as: MUSICKI BRANISLAV
23 granted patents·5 pending applications·146 citations·filing 1997–2023
94Inventor score
Top patents by PatentIndex Score
28 records- 0191US7439253B2Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitorsNOVEXEL·Filed 2003·Granted Oct 21, 2008·57 cites·23 claims
- 0287US7288549B2Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agentsAVENTIS PHARMA SA·Filed 2002·Granted Oct 30, 2007·26 cites·10 claims
- 0385US9650337B2Method of synthesising 4-piperidin-4-yl-benzene-1,3-diol and the salts of same and novel compound tert-butyl 4-(2,4-dihydroxy-phenyl)-4-hydroxy-piperidine-1-carboxylateGALDERMA RES & DEV·Filed 2014·Granted May 16, 2017·3 cites·14 claims
- 0484US10246440B2Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR γ (T))GALDERMA RES & DEV·Filed 2015·Granted Apr 2, 2019·2 cites·8 claims
- 0583US8148540B2Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agentsASZODI JOSEPH·Filed 2007·Granted Apr 3, 2012·9 cites·4 claims
- 0682US6579902B1Ribose-substituted aromatic amides, method for the production and use thereof as medicamentsAVENTIS PHARMA SA·Filed 2000·Granted Jun 17, 2003·21 cites·21 claims
- 0776US9090596B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologiesGALDERMA RES & DEV·Filed 2012·Granted Jul 28, 2015·3 cites·9 claims
- 0870US9580412B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesGALDERMA RES & DEV·Filed 2016·Granted Feb 28, 2017·1 cites·11 claims
- 0968US9526732B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologiesGALDERMA RES & DEV·Filed 2015·Granted Dec 27, 2016·1 cites·8 claims
- 1068US6812331B2Aromatic derivatives substituted by a ribose, their preparation process and their use as medicamentsAVENTIS PHARMA SA·Filed 2001·Granted Nov 2, 2004·4 cites·1 claims
- 1168US6583119B2Aromatic amides, preparation method and application as medicinesAVENTIS PHARMA SA·Filed 2002·Granted Jun 24, 2003·5 cites·17 claims
- 1267US9388149B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesGALDERMA RES & DEV·Filed 2012·Granted Jul 12, 2016·1 cites·10 claims
- 1366US10752617B2Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))GALDERMA RES & DEV·Filed 2019·Granted Aug 25, 2020·0 cites·19 claims
- 1463US10647706B2Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologiesGALDERMA RES & DEV·Filed 2019·Granted May 12, 2020·0 cites·13 claims
- 1561US2009018329A1Novel heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitorsNOVEXEL·Filed 2008·Application pending·0 cites
- 1658US10618890B2Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))GALDERMA RES & DEV·Filed 2015·Granted Apr 14, 2020·0 cites·13 claims
- 1758US10550110B2Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (t))GALDERMA RES & DEV·Filed 2015·Granted Feb 4, 2020·0 cites·20 claims
- 1858US7365071B2Heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as β-lactamase inhibitors and antibacterialsMUSICKI BRANISLAV·Filed 2003·Granted Apr 29, 2008·2 cites·17 claims
- 1958US2023279003A1Jak inhibitor compounds, method for synthesizing same and use thereofGalderma Holding SA·Filed 2023·Application pending·0 cites
- 2054US2010160401A14-phenylimidazole-2-thione tyrosinase inhibitors and treatment or prevention of pigmentary disorders therewithGALDERMA RES & DEV BIOT FRANCE·Filed 2009·Application pending·0 cites
- 2153US2009131660A1SYNTHESIS OF 3-[4-(1,1-DIMETHYL-PROPYL)-PHENYL]-2-METHYL-PROPIONALDEHYDE AND cis-4--2,6-DIMETHYL-MORPHOLINE (AMOROLFINE)GALDERMA SA·Filed 2008·Application pending·0 cites
- 2252US2007191312A1Novel heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as beta-lactamase inhibitors and antibacterialsMUSICKI BRANISLAV·Filed 2007·Application pending·0 cites
- 2349US9120772B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesGALDERMA RES & DEV·Filed 2012·Granted Sep 1, 2015·0 cites·6 claims
- 2445US6420538B1Aromatic amides, preparation method and application as medicinesAVENTIS PHARMA SA·Filed 1999·Granted Jul 16, 2002·7 cites·23 claims
- 2542US9415039B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesGALDERMA RES & DEV·Filed 2015·Granted Aug 16, 2016·0 cites·8 claims
- 2641US6350733B1Aromatic derivatives substituted by a ribose, their method of preparation and application as medicineAVENTIS PHARMA SA·Filed 1997·Granted Feb 26, 2002·4 cites·17 claims
- 2739US10287278B2Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologiesGALDERMA RES & DEV·Filed 2015·Granted May 14, 2019·0 cites·6 claims
- 2836US10457637B2Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (RORγ(T))GALDERMA RES & DEV·Filed 2015·Granted Oct 29, 2019·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Branislav Musicki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →